       Document 0160
 DOCN  M9610160
 TI    [Hepatitis C virus viremia and Herpes zoster virus infection in a
       patient in hemodialysis treated with erythropoietin]
 DT    9601
 AU    Duclos J; Departamento de Nefrologia, Hospital Naval, Vina del Mar,;
       Chile.
 SO    Rev Med Chil. 1995 Feb;123(2):225-8. Unique Identifier : AIDSLINE
       MED/96054137
 AB    Hepatitis C virus infection in chronic hemodialysis patients is
       associated with several unresolved problems. We report a 85 years old
       female patient in chronic hemodialysis and treated with erythropoietin,
       that during the course of an Herpes zoster, presented severe malaise,
       weight loss and muscle weakness. Two weeks later, a slight rise in serum
       transaminases was detected. The patient had negative antibodies for HIV
       and hepatitis C virus and negative hepatitis B surface antigen. A PCR
       test was positive for serum hepatitis C virus RNA. The patient's
       condition deteriorated and she died 7 days after admission.
       Erythropoietin administration, whose immunosuppressive effect has been
       reported previously, could have influenced the dismal outcome of this
       patient.
 DE    Aged  Aged, 80 and over  Blood Transfusion/ADVERSE EFFECTS  Case Report
       English Abstract  Erythropoietin/*ADVERSE EFFECTS  Female  Follow-Up
       Studies  *Hemodialysis  Hepatitis C/*COMPLICATIONS/ETIOLOGY  Herpes
       Zoster/*COMPLICATIONS  Human  Kidney Failure/COMPLICATIONS/THERAPY
       Viremia/*COMPLICATIONS  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

